Surgery/Specialties

Latest Issue of OR Manager
March 2025
Home Surgery/Specialties

Crisis management takes new leaders to the next level

Unexpected benefits can arise from unexpected circumstances. Relatively new nurse leaders at two different facilities have found this to be true, for different reasons. Both have faced sudden changes that made their jobs more difficult but also gave them opportunities for growth. When the director of ambulatory care at Brigham…

Read More

By: Elizabeth Wood
May 19, 2021
Share

Building a good 'marriage' with hospitals: A primer for ASCs

A global pandemic did not stop the proliferation of joint ventures between ambulatory surgery centers (ASCs) and hospitals in 2020. The trend continues in 2021, as federal regulators expand on the types of procedures that can be performed in the ambulatory setting. Hospitals are recognizing the need for a surgery…

Read More

By: Jennifer Lubell
May 19, 2021
Share

Study: Postop opioid prescriptions decreasing, but not to recommended levels

Editor's Note Opioids prescribed after outpatient surgery are going down, but still do not meet expert recommendations, a new study from Epic Health Research Network finds. The researchers examined the median number of opioid tablets prescribed after outpatient surgical procedures between January 2017 and December 2020. For four orthopedic procedures,…

Read More

By: Judy Mathias
May 18, 2021
Share

Trends in surgical caseloads during COVID-19

Editor's Note Urban hospitals bounced back faster than rural hospitals from surgical caseload decreases caused by the COVID-19 pandemic, finds a new study released May 13 by Caresyntax, a Boston-based developer of surgical intelligence and automation technologies. The study, “The State of Surgery: An Analysis of Surgical Trends During the…

Read More

By: Judy Mathias
May 17, 2021
Share

Sponsored Message

ECRI, national leaders collaborate on COVID-19 lessons for value analysis teams

Editor's Note ECRI and the Association for Healthcare Value Analysis Professionals (AHVAP) have partnered on a new white paper outlining key supply chain lessons and risk mitigation strategies learned from the COVID-19 pandemic. Among the lessons learned is the critical role physicians play in the value analysis process and that…

Read More

By: Judy Mathias
May 13, 2021
Share

Disparities persisted as orthopedic surgery patients shifted to telemedicine

Editor's Note This study by researchers at Harvard Medical School and Brigham and Women’s Hospital, Boston, finds that disparities in access to orthopedic care persisted as orthopedic surgical patients were shifted to telemedicine during COVID-19. The researchers analyzed nearly 2,000 orthopedic patients receiving care via telemedicine from March to May…

Read More

By: Judy Mathias
May 11, 2021
Share

Sponsored Message

COVID-19 has detrimental effect on surgical residents’ operative experience

Editor's Note This review study, led by researchers at the Harbor-University of California, Los Angeles Medical Center, Torrance, finds a significant negative effect of COVID-19 on general surgery residents’ operative experience. This retrospective review of 1,358 resident case logs from 16 general surgery programs in the US finds a 33.5%…

Read More

By: Judy Mathias
May 3, 2021
Share

Emotional outcomes of intraoperative deaths on surgical teams

Editor's Note This study from Cedars-Sinai Medical Center, Los Angeles, finds that intraoperative deaths negatively affect surgical team members, with a considerable number experiencing feelings of anger and depression. Of 120 OR team members completing a survey, 82 (68.3%) said they had prior experience with intraoperative deaths, referencing more than…

Read More

By: Judy Mathias
April 29, 2021
Share

FDA: Class I recall of Medtronic’s Extracorporeal Blood Pumping Console

Editor's Note The Food and Drug Administration (FDA), on April 20, identified the recall of Medtronic’s Bio-Console 560 Extracorporeal Blood Pumping Console as Class I, the most serious. The Console is used during heart surgery to pump and return blood to a patient during cardiopulmonary bypass. The recall was initiated…

Read More

By: Judy Mathias
April 22, 2021
Share

FDA issues Class I recall of certain Medtronic ICDs, CRT-Ds

Editor's Note The Food and Drug Administration (FDA), on April 12, identified the recall of Medtronic’s Evera, Viva, Brava, Claria, Amplia, Compia, and Visia implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) as Class I, the most serious. The recall was initiated because of an unexpected and rapid…

Read More

By: Judy Mathias
April 19, 2021
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat